Piramal Pharma Solutions to acquire G&W Laboratories' drug facility in US

The site has received certifications from the Food and Drug Administration and European Medicines Agency

Piramal Enterprises Ltd's pharma solutions business on Saturday said it had entered into a pact with G&W Laboratories Inc to acquire its solid oral dosage drug product manufacturing facility at Sellersville in US for $17.5 million (over Rs 130 crore).

"According to the terms of the agreement, Piramal Enterprises Ltd, through one of its affiliates, would acquire...100 per cent stake in the entity that operates the facility and owns the related real estate," Piramal Pharma Solutions (PPS) said in a statement.

This acquisition broadens the offering of Piramal Pharma Solutions by adding solid oral dosage form capabilities in North America.